ASSIGNMENT OF POSTTRANSLATIONAL MODIFICATIONS IN STREPTOLYSIN-S ANALOGUE
ASSIGNMENT OF POSTTRANSLATIONAL MODIFICATIONS IN STREPTOLYSIN-S ANALOGUE
批准号:
8168991
负责人:
JACK E DIXON
金额:
$0.19万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-01 至 2011-02-28
关键词:
BacteriaComputer Retrieval of Information on Scientific Projects DatabaseCysteineCytolysinsFundingGrantInstitutionMapsMass Spectrum AnalysisOxazolesPeptidesPhenotypePlayPost-Translational Protein ProcessingResearchResearch PersonnelResourcesRoleSerineSideSourceStreptococcus pyogenesStreptolysinsStructureThiazolesThreonineUnited States National Institutes of HealthVirulenceanalogperforin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Streptolysin S (SLS) is a potent cytolysin produced by Streptococcus Pyogenes. SLS plays a key role in virulence and is responsible for the b-hemolytic phenotype of these bacteria. To date, the structure of SLS has not been identified. Previous studies have shown that SLS is a heavily posttranslationally modified ribosomally encoded peptide. In order for the peptide to become cytolytic the side chains of one or more of the cysteine, serine or threonines are heterocyclized into five membered thiazole or oxazole rings. Repeated attempts to identify and map these posttranslational modifications by mass spectrometry have failed. This study will use NMR to do a sequential assignment by triple resonance on a recombinantly produced SLS analogue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lafora epilepsy mechanisms: insights into brain metabolism
-
批准号:9125528
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2016
-
负责人:JACK E DIXON
-
依托单位:
CHARACTERIZE THE FUNCTION OF PROTEIN TYROSINE PHOSPHATASE PTPMT1 IN MITOCHONDRIA
-
批准号:8361936
-
项目类别:
-
资助金额:$3.7万
-
财政年份:2011
-
负责人:JACK E DIXON
-
依托单位:
Phosphoinositide Phosphatases
-
批准号:8036713
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:JACK E DIXON
-
依托单位:
YopT: A Yersinia Virulence Factor
-
批准号:7052060
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2005
-
负责人:JACK E DIXON
-
依托单位:
YopT: A Yersinia Virulence Factor
-
批准号:6907659
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2005
-
负责人:JACK E DIXON
-
依托单位:
Fic-mediated Adenylylation
-
批准号:8509713
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2004
-
负责人:JACK E DIXON
-
依托单位:
Fic-mediated Adenylylation
-
批准号:8301740
-
项目类别:
-
资助金额:$32.22万
-
财政年份:2004
-
负责人:JACK E DIXON
-
依托单位:
Molecular Mechanism of Pathogenesis
-
批准号:7393692
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2004
-
负责人:JACK E DIXON
-
依托单位:
Molecular Mechanism of Pathogenesis
-
批准号:6894645
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2004
-
负责人:JACK E DIXON
-
依托单位:
Molecular Mechanism of Pathogenesis
-
批准号:6802631
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2004
-
负责人:JACK E DIXON
-
依托单位:
Molecular Mechanism of Pathogenesis
-
批准号:7058321
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2004
-
负责人:JACK E DIXON
-
依托单位:
Fic-mediated Adenylylation
-
批准号:7983434
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2004
-
负责人:JACK E DIXON
-
依托单位:
Molecular Mechanism of Pathogenesis
-
批准号:7214831
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2004
-
负责人:JACK E DIXON
-
依托单位:
Fic-mediated Adenylylation
-
批准号:8136229
-
项目类别:
-
资助金额:$32.13万
-
财政年份:2004
-
负责人:JACK E DIXON
-
依托单位:
Conference: Second Messengers & Protein Phosphorylation
-
批准号:6369306
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2001
-
负责人:JACK E DIXON
-
依托单位:
FASEB SUMMER CONFERENCE--RECEPTORS/SIGNAL TRANSDUCTION
-
批准号:6167217
-
项目类别:
-
资助金额:$1.7万
-
财政年份:2000
-
负责人:JACK E DIXON
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6105274
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1999
-
负责人:JACK E DIXON
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6314060
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1999
-
负责人:JACK E DIXON
-
依托单位:
PROTEIN TYROSINE PHOSPHATASES STRUCTURE/FUNCTION
-
批准号:2879637
-
项目类别:
-
资助金额:$7.75万
-
财政年份:1998
-
负责人:JACK E DIXON
-
依托单位:
PROTEIN TYROSINE PHOSPHATASE
-
批准号:6297134
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:JACK E DIXON
-
依托单位: